Both IRAK1 and IRAK4 are known to show true kinase activity and have been exclusively explored as targets in a variety of auto-immune and inflammatory diseases: rheumatoid arthritis, diabetes, and systemic lupus erythematosus, as well as in a few cancer cases in the scientific literature [205]. This evidence concerns the gene IRAK1 and cancer.